Creo Medical Braves Public Market To Score $25m IPO

Surgical endoscopy specialist Creo Medical Group plc has met its IPO target and raised £20m ($25m) ahead of its listing on the London Stock Exchange's Alternative Investment Market (AIM) on Friday 9 December.

Surgical endoscopy company Creo Medical tried its luck in the IPO market and raised £20m ($25m) ahead of its listing on the Alternative Investment Market (AIM) on Friday 9 December.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Gastroenterology

More from Device Area